The Trump administration has canceled an upcoming meeting of the
The Vaccines and Related Biological Products Advisory Committee, which evaluates immunization data for the FDA, had planned to meet in March to discuss the composition of next season’s flu vaccine. The meeting is a routine but critical step in ensuring manufacturers have sufficient time to produce
The meeting was originally planned for March 13, but several committee members ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.